S2M S2Medical AB (publ)

STO · SE · Healthcare · Medical Instruments & Supplies · s2m.se

0.0036SEK0.00%Mkt Cap: 419883 $P/E: —Today

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap419.88K USD

Enterprise Value258.30K USD

Revenue (TTM)1.42M USD

Gross Profit1.34M USD

Net Income (TTM)-965.48K USD

Revenue/Share0.02 SEK

Last Price0.0036 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees10

CountrySE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-1.98

EV/Revenue0.18

P/S0.29

P/B0.33

EPS (TTM)-0.01

EPS (Forward)—

52W Range

0.00323% of range0.0150

52W High0.0150 SEK

52W Low0.0032 SEK

Profitability

Gross Margin97.78%

Oper. Margin2.53%

EBITDA Margin-9.14%

Profit Margin-70.28%

ROE-102.23%

ROA-59.72%

Growth

Revenue Growth7.80%

Earnings Growth6.30%

Cash Flow & Leverage

Operating CF64.68K USD

CapEx (TTM)193.63K USD

FCF Margin-8.23%

FCF Yield-27.93%

Net Debt-53.95K USD

Net Debt/EBITDA0.41

Balance Sheet

Debt/Equity0.00

Current Ratio0.58

Quick Ratio0.34

Book Value/Sh0.01 SEK

Cash/Share0.0010 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.21B

Float—

Insiders23.63%

Institutions12.43%

Technical

SMA 500.0054 (-33.7%)

SMA 2000.0074 (-51.3%)

Beta2.33

S&P 52W Chg14.58%

Avg Vol (30d)8.96M

Avg Vol (10d)7.19M

Technical Indicators

RSI (14)35.8

MACD-0.0003

MACD Signal-0.0002

MACD Hist.-0.0001

BB Upper0.0063 SEK

BB Middle0.0053 SEK

BB Lower0.0043 SEK

BB Width36.54%

ATR (14)0.0010 SEK

Vol Ratio (20d)30.28x